PACIRA BIOSCIENCES, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
PACIRA BIOSCIENCES, INC. (PCRX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 8.29 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-04
- PACIRA BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 8.29M shares, a 42.73% decline year-over-year.
- PACIRA BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 8.18M shares, a 31.01% decline year-over-year.
- PACIRA BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 8.99M shares, a 27.67% decline year-over-year.
- PACIRA BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 14.48M shares, a 68.11% increase year-over-year.
- PACIRA BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 9.83M shares, a 25.81% decline from fiscal 2024.
- PACIRA BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 13.25M shares, a 81.45% increase from fiscal 2023.
- PACIRA BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 7.30M shares, a 22.72% decline from fiscal 2022.
- PACIRA BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 9.45M shares, a 316.34% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 8.29M shares 10-Q · filed 2026-08-04 | 8.24M shares 10-Q · filed 2026-08-04 | ||||
| 2026-03-31 | 8.18M shares 10-Q · filed 2026-04-30 | |||||
| 2025-12-31 | 9.83M shares 10-K · filed 2026-02-26 | |||||
| 2025-09-30 | 8.99M shares 10-Q · filed 2025-11-06 | 10.61M shares 10-Q · filed 2025-11-06 | ||||
| 2025-06-30 | 14.48M shares 10-Q · filed 2026-08-04 | 14.26M shares 10-Q · filed 2026-08-04 | ||||
| 2025-03-31 | 11.86M shares 10-Q · filed 2026-04-30 | |||||
| 2024-12-31 | 13.25M shares 10-K · filed 2026-02-26 | |||||
| 2024-09-30 | 12.43M shares 10-Q · filed 2025-11-06 | 13.47M shares 10-Q · filed 2025-11-06 | ||||
| 2024-06-30 | 8.62M shares 10-Q · filed 2025-08-05 | 8.78M shares 10-Q · filed 2025-08-05 | ||||
| 2024-03-31 | 8.94M shares 10-Q · filed 2025-05-08 | |||||
| 2023-12-31 | 7.30M shares 10-K · filed 2026-02-26 | |||||
| 2023-09-30 | 8.45M shares 10-Q · filed 2024-11-06 | 12.53M shares 10-Q · filed 2024-11-06 | ||||
| 2023-06-30 | 6.11M shares 10-Q · filed 2024-07-30 | 11.77M shares 10-Q · filed 2024-07-30 | ||||
| 2023-03-31 | 13.16M shares 10-Q · filed 2024-05-07 | |||||
| 2022-12-31 | 9.45M shares 10-K · filed 2025-02-27 | |||||
| 2022-09-30 | 13.13M shares 10-Q · filed 2023-11-02 | 3.51M shares 10-Q · filed 2023-11-02 | ||||
| 2022-06-30 | 1.98M shares 10-Q · filed 2023-08-02 | 3.08M shares 10-Q · filed 2023-08-02 | ||||
| 2022-03-31 | 9.78M shares 10-Q · filed 2023-05-03 | |||||
| 2021-12-31 | 2.27M shares 10-K · filed 2024-02-29 | |||||
| 2021-09-30 | 3.10M shares 10-Q · filed 2022-11-03 | 2.04M shares 10-Q · filed 2022-11-03 | ||||
| 2021-06-30 | 2.11M shares 10-Q · filed 2022-08-03 | 1.50M shares 10-Q · filed 2022-08-03 | ||||
| 2021-03-31 | 892.00K shares 10-Q · filed 2022-05-04 | |||||
| 2020-12-31 | 4.35M shares 10-K · filed 2023-02-28 | |||||
| 2020-09-30 | 3.62M shares 10-Q · filed 2021-11-03 | 4.89M shares 10-Q · filed 2021-11-03 | ||||
| 2020-06-30 | 7.52M shares 10-Q · filed 2021-08-03 | 5.53M shares 10-Q · filed 2021-08-03 | ||||
| 2020-03-31 | 5.38M shares 10-Q · filed 2021-05-04 | |||||
| 2019-12-31 | 7.04M shares 10-K · filed 2022-02-28 | |||||
| 2019-09-30 | 5.74M shares 10-Q · filed 2020-10-30 | 4.99M shares 10-Q · filed 2020-10-30 | ||||
| 2019-06-30 | 4.62M shares 10-Q · filed 2020-08-06 | 6.54M shares 10-Q · filed 2020-08-06 | ||||
| 2019-03-31 | 6.39M shares 10-Q · filed 2020-05-07 | |||||
| 2018-12-31 | 6.07M shares 10-K · filed 2021-03-01 | |||||
| 2018-09-30 | 6.63M shares 10-Q · filed 2019-11-08 | 5.95M shares 10-Q · filed 2019-11-08 | ||||
| 2018-06-30 | 4.29M shares 10-Q · filed 2019-08-08 | 5.61M shares 10-Q · filed 2019-08-08 | ||||
| 2018-03-31 | 5.56M shares 10-Q · filed 2019-05-02 | |||||
| 2017-12-31 | 6.06M shares 10-K · filed 2020-02-21 | |||||
| 2017-09-30 | 5.98M shares 10-Q · filed 2018-11-01 | 6.21M shares 10-Q · filed 2018-11-01 | ||||
| 2017-06-30 | 5.51M shares 10-Q · filed 2018-08-02 | 6.32M shares 10-Q · filed 2018-08-02 | ||||
| 2017-03-31 | 7.13M shares 10-Q · filed 2018-05-03 | |||||
| 2016-12-31 | 6.82M shares 10-K · filed 2019-02-28 | |||||
| 2016-09-30 | 6.77M shares 10-Q · filed 2017-11-08 | 6.98M shares 10-Q · filed 2017-11-08 | ||||
| 2016-06-30 | 6.84M shares 10-Q · filed 2017-08-02 | 7.07M shares 10-Q · filed 2017-08-02 | ||||
| 2016-03-31 | 7.30M shares 10-Q · filed 2017-05-04 | |||||
| 2015-12-31 | 2.00M shares 10-K · filed 2018-02-28 | |||||
| 2015-09-30 | 2.45M shares 10-Q · filed 2016-11-02 | 1.84M shares 10-Q · filed 2016-11-02 | ||||
| 2015-06-30 | 1.74M shares 10-Q · filed 2016-08-04 | 1.53M shares 10-Q · filed 2016-08-04 | ||||
| 2015-03-31 | 1.32M shares 10-Q · filed 2016-05-02 | |||||
| 2014-12-31 | 6.04M shares 10-K · filed 2017-03-01 | 6.04M shares 10-K · filed 2016-02-25 | ||||
| 2014-09-30 | 8.47M shares 10-Q · filed 2015-10-27 | 7.64M shares 10-Q · filed 2015-10-27 | ||||
| 2014-06-30 | 7.45M shares 10-Q · filed 2015-07-30 | 7.22M shares 10-Q · filed 2015-07-30 | ||||
| 2014-03-31 | 7.00M shares 10-Q · filed 2015-04-30 | 5.10M shares 10-Q · filed 2014-05-01 | ||||
| 2013-12-31 | 5.38M shares 10-K · filed 2016-02-25 | 3.38M shares 10-K · filed 2014-02-25 | ||||
| 2013-03-31 | 2.00M shares 10-Q · filed 2014-05-01 | 1.96M shares 10-Q · filed 2013-05-08 | ||||
| 2012-12-31 | 3.89M shares 10-K · filed 2015-02-24 | 1.44M shares 10-K · filed 2013-03-07 | ||||
| 2012-03-31 | 1.28M shares 10-Q · filed 2013-05-08 | |||||
| 2011-12-31 | 1.29M shares 10-K · filed 2014-02-25 | |||||
| 2010-12-31 | 8.89M shares 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |